Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fractional Flow Reserve, Myocardial | 39 | 2023 | 289 | 8.470 |
Why?
|
Coronary Stenosis | 27 | 2023 | 833 | 4.350 |
Why?
|
Coronary Artery Disease | 32 | 2023 | 6485 | 2.680 |
Why?
|
Coronary Vessels | 28 | 2023 | 3106 | 2.540 |
Why?
|
Hyperemia | 13 | 2022 | 225 | 2.070 |
Why?
|
Coronary Circulation | 9 | 2020 | 1572 | 1.840 |
Why?
|
Drug-Eluting Stents | 8 | 2022 | 753 | 1.530 |
Why?
|
Coronary Angiography | 33 | 2023 | 4576 | 1.400 |
Why?
|
Microcirculation | 15 | 2021 | 1287 | 1.230 |
Why?
|
Coronary Sinus | 4 | 2022 | 87 | 1.180 |
Why?
|
Troponin I | 3 | 2019 | 619 | 1.090 |
Why?
|
Magnetic Resonance Imaging, Cine | 5 | 2021 | 962 | 1.090 |
Why?
|
Predictive Value of Tests | 33 | 2023 | 15067 | 0.860 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2022 | 251 | 0.830 |
Why?
|
Transducers, Pressure | 2 | 2019 | 56 | 0.810 |
Why?
|
Tooth Loss | 1 | 2023 | 196 | 0.770 |
Why?
|
Tomography, Optical Coherence | 14 | 2020 | 2657 | 0.730 |
Why?
|
Methylamines | 1 | 2020 | 122 | 0.710 |
Why?
|
Vascular Resistance | 10 | 2020 | 936 | 0.700 |
Why?
|
Neointima | 5 | 2019 | 135 | 0.690 |
Why?
|
Plaque, Atherosclerotic | 10 | 2022 | 1518 | 0.680 |
Why?
|
Catheter Ablation | 5 | 2019 | 2758 | 0.680 |
Why?
|
Pericardiocentesis | 1 | 2018 | 74 | 0.650 |
Why?
|
Blood Flow Velocity | 8 | 2022 | 1423 | 0.650 |
Why?
|
Cholesterol, HDL | 2 | 2022 | 1813 | 0.630 |
Why?
|
Acute Coronary Syndrome | 6 | 2020 | 2337 | 0.610 |
Why?
|
Cardiac Tamponade | 1 | 2018 | 173 | 0.600 |
Why?
|
Severity of Illness Index | 17 | 2022 | 15526 | 0.560 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15142 | 0.550 |
Why?
|
Diet, Mediterranean | 1 | 2022 | 700 | 0.520 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2024 | 11729 | 0.520 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 717 | 0.510 |
Why?
|
Walking | 1 | 2022 | 1182 | 0.500 |
Why?
|
Body Temperature | 1 | 2018 | 774 | 0.500 |
Why?
|
Catheters | 1 | 2017 | 424 | 0.490 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1525 | 0.490 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2020 | 555 | 0.480 |
Why?
|
Polytetrafluoroethylene | 1 | 2015 | 233 | 0.480 |
Why?
|
PPAR-beta | 1 | 2013 | 5 | 0.470 |
Why?
|
PPAR delta | 1 | 2013 | 43 | 0.460 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1885 | 0.430 |
Why?
|
Prognosis | 20 | 2023 | 29052 | 0.420 |
Why?
|
Pulmonary Edema | 1 | 2015 | 414 | 0.420 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2354 | 0.410 |
Why?
|
Treatment Outcome | 30 | 2023 | 63042 | 0.400 |
Why?
|
Cardiology | 1 | 2023 | 1668 | 0.400 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1195 | 0.400 |
Why?
|
Registries | 9 | 2022 | 8090 | 0.370 |
Why?
|
I-kappa B Kinase | 1 | 2012 | 252 | 0.370 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1572 | 0.360 |
Why?
|
Middle Aged | 46 | 2022 | 213241 | 0.360 |
Why?
|
Japan | 5 | 2020 | 1360 | 0.360 |
Why?
|
Aged | 46 | 2022 | 163178 | 0.350 |
Why?
|
Humans | 82 | 2024 | 743811 | 0.330 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3338 | 0.330 |
Why?
|
Graft Occlusion, Vascular | 1 | 2012 | 549 | 0.320 |
Why?
|
Vascular System Injuries | 1 | 2012 | 250 | 0.320 |
Why?
|
Insulin Resistance | 1 | 2021 | 3863 | 0.300 |
Why?
|
Ultrasonography, Interventional | 4 | 2020 | 1486 | 0.300 |
Why?
|
Male | 53 | 2023 | 349776 | 0.300 |
Why?
|
Femoral Artery | 1 | 2012 | 845 | 0.300 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2017 | 1874 | 0.280 |
Why?
|
Hemodynamics | 4 | 2021 | 4197 | 0.280 |
Why?
|
Female | 51 | 2024 | 380020 | 0.280 |
Why?
|
Benzamides | 1 | 2012 | 1383 | 0.270 |
Why?
|
Thiazoles | 1 | 2013 | 1482 | 0.270 |
Why?
|
Peptide Fragments | 1 | 2018 | 5096 | 0.270 |
Why?
|
Blood Pressure | 3 | 2019 | 8551 | 0.270 |
Why?
|
Risk Factors | 18 | 2024 | 72252 | 0.250 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11708 | 0.250 |
Why?
|
Rest | 2 | 2020 | 901 | 0.250 |
Why?
|
Republic of Korea | 3 | 2020 | 538 | 0.240 |
Why?
|
Telemedicine | 1 | 2021 | 2874 | 0.230 |
Why?
|
Aortic Diseases | 2 | 2020 | 743 | 0.230 |
Why?
|
Cryosurgery | 2 | 2019 | 453 | 0.230 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5752 | 0.230 |
Why?
|
Adipose Tissue | 5 | 2021 | 3280 | 0.220 |
Why?
|
Inflammation | 8 | 2023 | 10629 | 0.210 |
Why?
|
Diet | 1 | 2020 | 7930 | 0.210 |
Why?
|
Pulmonary Veins | 2 | 2019 | 761 | 0.210 |
Why?
|
Electrocardiography | 5 | 2021 | 6441 | 0.210 |
Why?
|
Stents | 5 | 2020 | 3280 | 0.210 |
Why?
|
Thermodilution | 2 | 2021 | 52 | 0.210 |
Why?
|
Spain | 2 | 2020 | 464 | 0.210 |
Why?
|
Magnetic Resonance Angiography | 2 | 2018 | 1444 | 0.200 |
Why?
|
Equipment Design | 3 | 2019 | 3574 | 0.200 |
Why?
|
Preoperative Period | 2 | 2020 | 550 | 0.190 |
Why?
|
Shellfish | 1 | 2020 | 38 | 0.190 |
Why?
|
Postoperative Period | 3 | 2020 | 1841 | 0.190 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2022 | 364 | 0.190 |
Why?
|
Atrial Fibrillation | 4 | 2021 | 5033 | 0.180 |
Why?
|
Angioscopy | 1 | 2019 | 49 | 0.180 |
Why?
|
Atrioventricular Block | 1 | 2021 | 120 | 0.170 |
Why?
|
Reproducibility of Results | 9 | 2020 | 19894 | 0.170 |
Why?
|
Thermometers | 1 | 2019 | 46 | 0.170 |
Why?
|
Retrospective Studies | 22 | 2022 | 77410 | 0.170 |
Why?
|
Heart Failure | 1 | 2023 | 10896 | 0.170 |
Why?
|
Prospective Studies | 14 | 2022 | 53250 | 0.170 |
Why?
|
Kidney Diseases, Cystic | 1 | 2020 | 186 | 0.160 |
Why?
|
Titanium | 1 | 2020 | 487 | 0.150 |
Why?
|
Fishes | 1 | 2020 | 569 | 0.150 |
Why?
|
Heart Function Tests | 1 | 2017 | 328 | 0.140 |
Why?
|
Cluster Analysis | 2 | 2021 | 2712 | 0.140 |
Why?
|
Secondary Prevention | 1 | 2023 | 1529 | 0.140 |
Why?
|
Radio Waves | 1 | 2017 | 251 | 0.140 |
Why?
|
Body Surface Potential Mapping | 1 | 2017 | 238 | 0.130 |
Why?
|
Myocardial Revascularization | 1 | 2020 | 841 | 0.130 |
Why?
|
Heart Conduction System | 2 | 2018 | 1047 | 0.130 |
Why?
|
Atrial Flutter | 1 | 2017 | 263 | 0.130 |
Why?
|
Atherosclerosis | 3 | 2021 | 3445 | 0.130 |
Why?
|
Equipment Failure Analysis | 1 | 2017 | 864 | 0.130 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2020 | 858 | 0.120 |
Why?
|
Aortic Aneurysm, Abdominal | 2 | 2021 | 1187 | 0.120 |
Why?
|
Ventricular Function, Right | 1 | 2018 | 589 | 0.120 |
Why?
|
Coronary Occlusion | 1 | 2017 | 304 | 0.120 |
Why?
|
Materials Testing | 1 | 2018 | 866 | 0.120 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2023 | 1004 | 0.120 |
Why?
|
Rupture, Spontaneous | 3 | 2019 | 354 | 0.120 |
Why?
|
Coronary Thrombosis | 1 | 2017 | 495 | 0.120 |
Why?
|
Sirolimus | 2 | 2018 | 1565 | 0.120 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 1184 | 0.120 |
Why?
|
Odds Ratio | 3 | 2024 | 9848 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6539 | 0.120 |
Why?
|
Electric Impedance | 1 | 2017 | 729 | 0.120 |
Why?
|
Constriction, Pathologic | 1 | 2017 | 1108 | 0.110 |
Why?
|
Cerebral Infarction | 1 | 2018 | 1011 | 0.110 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39001 | 0.110 |
Why?
|
Coronary Artery Bypass | 1 | 2022 | 2288 | 0.110 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25032 | 0.110 |
Why?
|
Contrast Media | 2 | 2016 | 5301 | 0.100 |
Why?
|
Microvessels | 1 | 2016 | 544 | 0.100 |
Why?
|
Aorta | 1 | 2019 | 2062 | 0.100 |
Why?
|
Lipids | 2 | 2022 | 3307 | 0.100 |
Why?
|
Time Factors | 11 | 2020 | 40038 | 0.100 |
Why?
|
Injections, Intraperitoneal | 1 | 2012 | 424 | 0.100 |
Why?
|
Propensity Score | 1 | 2018 | 1781 | 0.100 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2012 | 286 | 0.100 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 633 | 0.100 |
Why?
|
Life Style | 1 | 2022 | 3833 | 0.090 |
Why?
|
Postoperative Complications | 3 | 2019 | 15281 | 0.090 |
Why?
|
Hyperplasia | 1 | 2013 | 1185 | 0.090 |
Why?
|
Tachycardia, Ventricular | 1 | 2018 | 1272 | 0.090 |
Why?
|
Tunica Intima | 1 | 2012 | 463 | 0.090 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2013 | 688 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5952 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2018 | 5078 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12243 | 0.080 |
Why?
|
Cytokines | 2 | 2013 | 7324 | 0.080 |
Why?
|
Artifacts | 1 | 2016 | 1904 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2503 | 0.070 |
Why?
|
Dyspnea | 1 | 2015 | 1303 | 0.070 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2013 | 1503 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2013 | 10477 | 0.070 |
Why?
|
Age Factors | 2 | 2021 | 18355 | 0.070 |
Why?
|
Risk Assessment | 4 | 2020 | 23327 | 0.070 |
Why?
|
Adult | 5 | 2022 | 213889 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2018 | 3817 | 0.070 |
Why?
|
Hypertension | 2 | 2023 | 8480 | 0.070 |
Why?
|
Myocardium | 1 | 2018 | 4775 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4033 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3283 | 0.060 |
Why?
|
Exercise | 1 | 2021 | 5611 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 21824 | 0.060 |
Why?
|
Regeneration | 1 | 2013 | 1486 | 0.060 |
Why?
|
Ultrasonography | 1 | 2017 | 5986 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12354 | 0.060 |
Why?
|
Incidence | 2 | 2021 | 20948 | 0.060 |
Why?
|
Blotting, Western | 1 | 2012 | 5179 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2013 | 18027 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12718 | 0.060 |
Why?
|
Anticoagulants | 1 | 2018 | 4599 | 0.060 |
Why?
|
Databases, Factual | 4 | 2019 | 7729 | 0.060 |
Why?
|
Prevalence | 4 | 2019 | 15211 | 0.050 |
Why?
|
Disease Progression | 2 | 2021 | 13273 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2022 | 20121 | 0.050 |
Why?
|
Animals | 3 | 2020 | 168660 | 0.040 |
Why?
|
Asia | 1 | 2020 | 609 | 0.040 |
Why?
|
Macrophages | 1 | 2013 | 5651 | 0.040 |
Why?
|
Logistic Models | 3 | 2019 | 13404 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 2021 | 646 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11360 | 0.040 |
Why?
|
Systole | 1 | 2020 | 958 | 0.040 |
Why?
|
Diastole | 1 | 2020 | 791 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2013 | 19232 | 0.040 |
Why?
|
False Negative Reactions | 1 | 2018 | 588 | 0.040 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2022 | 717 | 0.040 |
Why?
|
Lung | 1 | 2015 | 9858 | 0.030 |
Why?
|
Mice | 2 | 2013 | 81154 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 980 | 0.030 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 644 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1676 | 0.030 |
Why?
|
Metabolomics | 1 | 2024 | 1487 | 0.030 |
Why?
|
China | 1 | 2020 | 2243 | 0.030 |
Why?
|
Necrosis | 1 | 2018 | 1642 | 0.030 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2020 | 691 | 0.030 |
Why?
|
Fibrosis | 1 | 2019 | 2030 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2017 | 1203 | 0.030 |
Why?
|
Observer Variation | 1 | 2018 | 2592 | 0.030 |
Why?
|
Action Potentials | 1 | 2019 | 1804 | 0.030 |
Why?
|
Recovery of Function | 1 | 2022 | 2922 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57744 | 0.020 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2017 | 851 | 0.020 |
Why?
|
Heart Rate | 1 | 2019 | 4091 | 0.020 |
Why?
|
Sleep | 1 | 2023 | 4619 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 40545 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10251 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10394 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 35409 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16361 | 0.010 |
Why?
|
Thrombosis | 1 | 2017 | 2968 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3255 | 0.010 |
Why?
|
Pregnancy | 1 | 2024 | 29140 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 56392 | 0.010 |
Why?
|
Kidney | 1 | 2017 | 7185 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 21733 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 85729 | 0.010 |
Why?
|
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_